- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Lisdexamfetamine – July 2013
Lisdexamfetamine, capsules, 30 mg, 50 mg, and 70 mg, Vyvanse®
Last updated
8 November 2023